04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
Yet again, the end of the year is rapidly approaching! To avoid costly penalties that can arise from...
Read More >
Your company has just made its largest acquisition ever and your CEO says they want you to have a co...
Read More >
Employers and employees are continually feeling the pinch of rising health care costs. 2020 provides...
Read More >
Here is a brief summary of the measures in the March 2020 Budget which are relevant to the Real Esta...
Read More >
On the eve of the holidays, the National Labor Relations Board (NLRB) delivered an early Christmas p...
Read More >
United States businesses lose an average of seven percent of their annual revenues to employee theft...
Read More >